디티앤씨알오
383930KOSDAQ자연과학 및 공학 연구개발업54.8 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
DT&CR is a Full-Service CRO providing non-clinical and clinical trial services across pharmaceuticals, medical devices, and health functional foods, offering integrated solutions from early-stage drug development to FDA approval. In 2025, revenue increased by 32.7% year-over-year to 47.7 billion won, driven by specialized services such as the expanded PK/PD center, which scientifically analyzes drug candidate characteristics.
Number of Employees
314people
Average Salary
47.4M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Well below industry avg
7.4x industry avg (risky)
Avg ▲34.0% (2-year basis)
Avg ▲28.0% (2-year basis)
Avg ROE -19.9% (improving, 3yr)
Detailed News Sentiment
- Positive디티앤씨알오, BIO USA 2026 한국관 참가…통합 CRO 역량 선...
디티앤씨알오의 BIO USA 2026 참가로 글로벌 네트워크 확장 및 CRO 역량 강화 기대.
- Positive"통합 CRO 플랫폼 알린다" 디티앤씨알오, '바이오 USA' 참가
디티앤씨알오의 글로벌 바이오 전시회 참가로 통합 CRO 플랫폼의 인지도 향상 기대.
- Positive디티앤씨알오, 한국비임상시험연구회 워크숍 참가… 비임상 개발 전략...
디티앤씨알오는 KSNS 워크숍에서 비임상 개발 전략을 공유하며 통합형 CRO 서비스 수요를 확인, 긍정적인 시장 반응을 이끌어냈다.
Detailed Momentum
Near 52w low (8%, downtrend)
1m -31.88% (strong drop)
Volume flat
Detailed Disclosure
- Neutral[기재정정]분기보고서 (2026.03)2026-05-18
- Neutral분기보고서 (2026.03)2026-05-15
- Neutral[기재정정]분기보고서 (2026.03)2026-05-15
